Pathologic evaluation for antibody-mediated rejection: prognostic vs diagnostic markers?
E Rene
ER
Rodriguez
Carmela D
CD
Tan
D056704:Adaptive Immunity / Q000502:physiology; D000906:Antibodies / Q000097:blood / Q000276:immunology / Q000502:physiology*; D015415:Biomarkers / Q000097:blood; D015933:Complement C3d / Q000378:metabolism; D015935:Complement C4b; D006084:Graft Rejection / Q000175:diagnosis* / Q000276:immunology*; D006684:HLA-DR Antigens / Q000097:blood; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D010446:Peptide Fragments / Q000097:blood; D011379:Prognosis; D016016:Proportional Hazards Models
D000906:Antibodies; D015415:Biomarkers; D006684:HLA-DR Antigens; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D010446:Peptide Fragments; D015933:Complement C3d; D015935:Complement C4b; C032261:complement C4d